AI assistant
Sending…
STAAR SURGICAL CO — Director's Dealing 2021
Mar 15, 2021
31996_dirs_2021-03-15_75ac135d-4dbd-4e57-b45c-64804ef6a961.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-03-12
Reporting Person: Blickensdoerfer Hans-Martin (Sr. VP, Comm. Ops, China)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-12 | Common Stock Options | $90.38 | M | 11154 | Acquired | 2031-03-11 | Common Stock (11154) | Direct |
Footnotes
F1: The options granted become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024.
More from STAAR SURGICAL CO
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
May 12
Annual Report
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 20
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27